EU Health Commissioner Stella Kyriakides orders 10,000 treatment courses for Monkeypox

By 2 months ago

EU Commissioner for Health and Food Safety Stella Kyriakides announced that the Commission has secured over 10,000 treatment courses of tecovirimat to treat Monkeypox. The emergency procurement is funded by the Health Emergency Preparedness and Response Authority (HERA) and channelled via rescEU to treat patients in Member States with immediate needs. Tecovirimat is produced by the pharmaceutical company Meridian/SIGA.

“Today, with our Health Emergency Preparedness and Response Authority, we have secured over 10,000 treatment courses to help those affected by Monkeypox. In addition to the over 330,000 vaccines already purchased by the EU, with these treatments we will help Member States meet immediate needs and ensure care for more patients in Europe. The declining trend of Monkeypox cases in the EU is encouraging but it does not mean that the threat has passed or that we can lower our guard. Preparedness is the fundament of our European Health Union.” noted Kyriakides.

Commissioner for Crisis Management, Janez Lenarčič said: “Monkeypox is one of the priority threats identified as part of the rescEU strategic reserves. These batches of monkeypox antivirals will offer an additional level of protection our citizens. The stocks will be available to Member States on an urgent needs-basis.”

From the onset of the monkeypox outbreak, the Commission has been closely following the evolution of the disease in Europe and supporting the preparedness and response efforts of all Member States. The purchase and donation of over 334,000 vaccine doses, produced by Bavarian Nordic, is just one example of the support being provided to Member States. One of the key goals of HERA is to ensure the development, manufacturing, procurement, and equitable distribution of key medical countermeasures.

 

Advertisment
Copyright GreekCityTimes 2022
Share
Copyright GreekCityTimes 2022